YOUR STRATEGIC PARTNER

IN HEALTHCARE & LIFE SCIENCE MARKETING

YOU ARE

A Life Science or a Healthcare Professional. Your Company, whatever its size, is focused on improving health and has ambitious growth projects. You have to deal with an ever increasing market complexity, aggressive competition and a heterogeneous audience to be informed and educated.

WE ARE

Specialized in Marketing, Communication and Business Development in the Life Science and Healthcare environment. Lifency has been designed to support you in realizing your projects and achieving your business objectives. Our outstanding experience and our consolidated methodology make the difference you need.

More about us

OUR SERVICES

MARKET PLANNING

BUSINESS DEVELOPMENT

DIGITAL MARKETING

COMMUNITY MANAGEMENT

LATEST NEWS

What did we learn on the efficacy and safety of covid19 vaccines ?

Controversies seem to be waning with new scientific data being publish on a regular basis. In a very recent paper*, Carolina Grana Possamai et al. conclude, after having analyzed 41 randomized clinicaltrials assessing 12 different vaccines, that:...

How is the future of deeplearning in medicine?

The following example is in contrast enhanced ultrasound ; ceus ; as reported by Qin-Xian Zhao et al.* who developed a DL model based on quantitative analysis of contrast-enhanced ultrasound (CEUS) images that predicts early recurrence...

How will mRNA – based therapeutics revolutionize the pharmaceutical industry ?

Do you have your own idea? If you need elements of answer, we suggest reading the very exhaustive review by Musga Qureischi , Julia Mohr , Estibaliz Arellano , Sarah Elspeth Knudsen , Farrukh Vohidovn and Andoni...

Transcriptomics beyond genomics: promising clinical application

Transcriptomics, beyond genomics and beneath proteomics provide us with precious information on geneexpression and have promising clinical applications. In their recent paper Kelley Nunez et al. from Ochsner Health in New Orleans present one of them that, through a...

Is there any “magic pill“ to improve your business performance?

A yes answer would not be fair... a no answer would not be true... so what? Well, think about what's happening in your business... progress relates to the ability to diagnose and treat more and more conditions through more and more pathways and in a more and...

The constantly changing landscape of type2 diabetes treatment

An update and indications on future directions are available in the very interesting paper* from Antea DeMarsilis just published in Metabolism It presents each class of agents by: ✔️mechanism of action✔️details of administration ✔️side effect profile✔️...

We support you achieving your market access objectives !

biotech, pharma, medtech and lifescience Companies rely on us to develop their international market presence and access new b2b markets in switzerland and in the european union. From the market access strategy to the local operations, direct or through a network of...

Proteomics allows a better understanding of the pathophysiology of Alzheimer disease

Proteomics allows a better understanding of the physiopathology of alzheimersdisease This statement is suggested and supported by: an amazing and comprehensive paper(1) by Sruti Rayaprolu et al. from Emory University school of medicine in Atlanta explains how and why...

CKD: Chronic Kidney Disease a devastating condition silently reaching epidemic levels

Even though nobody's publishing epidemiological and mortality data every day CKD, Marta Ruiz-Ortega et al from Universidad Autónoma de Madrid reminds us in an interesting paper that this condition is progressing as a consequence of (besides the aging of...

Today’s a great Day for Life Science

Today’s a great Day for us, a great Day for Life Science, a great Day for the thousands of people working for Moderna and a great Day for him, Stéphane Bancel. FDA has issued an emergency use authorization for Moderna’s COVID 19 vaccine, few days after the Pfizer...